Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies
Author:
Affiliation:
1. Department of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35116, Egypt
2. Institute of Translational Pharmacology (IFT)-CNR, 00133 Rome, Italy
Abstract
Publisher
MDPI AG
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Link
https://www.mdpi.com/2227-9059/11/2/627/pdf
Reference10 articles.
1. Beck, C., Casey, N.P., Persiconi, I., Moharrami, N.N., Sike, A., Jin, Y., and Kyte, J.A. (2023). Development of a TGFβ—IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy. Biomedicines, 11.
2. Georgiou-Siafis, S.K., Miliotou, A.N., Ntenti, C., Pappas, I.S., and Papadopoulou, L.C. (2022). An Innovative PTD-IVT-mRNA Delivery Platform for CAR Immunotherapy of ErbB (+) Solid Tumor Neoplastic Cells. Biomedicines, 10.
3. Atar, D., Mast, A.S., Scheuermann, S., Ruoff, L., Seitz, C.M., and Schlegel, P. (2022). Adapter CAR T Cell Therapy for the Treatment of B-Lineage Lymphomas. Biomedicines, 10.
4. Deshet-Unger, N., Horn, G., Rawet-Slobodkin, M., Waks, T., Laskov, I., Michaan, N., Raz, Y., Bar, V., Zundelevich, A., and Aharon, S. (2022). Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer. Biomedicines, 10.
5. Pedersen, M.G., Møller, B.K., and Bak, R.O. (2022). Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AML. Biomedicines, 10.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3